Global 3D Printed Drugs Market exhibited a value of USD 214.3 million Global 3D Printed Drugs Market exhibited a value o | Page 3

Key takeaways:
•
In 2017, more than half of the market share was held by the fused deposition
modeling technique.
•
Apprecia Pharmaceuticals, GlaxoSmithKline and FabRx Ltd, and Hewlett
Packard are the leading players holding approximately around one-third of the
market share.
•
The inkjet printer product type is anticipated to grow at the highest rate
during the forecast period from 2018 to 2025.
•
In 2017, North America held the largest share in the 3D printed drugs market.
Some of the key players operating in the global 3D printed drugs market include
3D Printer Drug Machine, Aprecia Pharmaceuticals, FabRx Ltd, GlaxoSmithKline
Plc., Hewlett Packard Caribe, BV, National University of Singapore, The
University of Nottingham, UCL School of Pharmacy, University College of London,
University of Glasgow and others.
The global 3D printed drugs market has been segmented on the basis of
technique type and key geographies. Based on technique type, the global 3D
drugs market comprises of fused deposition modeling, inkjet printers, and others
also including key geographical areas.
The research report on 3D drugs market provides an in-depth analysis of the
global 3D printed drugs market, based on technique type and major geographies
for the forecast period from 2018 to 2025. The report highlights the major market
drivers propelling the growth as well as challenges faced by the market
participants. The research report also provides market size and forecast for 3D
printed drug market. The report also analyses the competitive landscape, major
players and their strategies in 2018. The competitive landscape section of the
report captures and highlights the recent developments in the market.